Jci_page_head_homepage_01 Jci_page_head_homepage_02
Rosa Bacchetta, Laura Passerini, Eleonora Gambineri, Minyue Dai, Sarah E. Allan, Lucia Perroni, Franca Dagna-Bricarelli, Claudia Sartirana, Susanne Matthes-Martin, Anita Lawitschka, Chiara Azzari, Steven F. Ziegler, Megan K. Levings, Maria Grazia Roncarolo
Published in Volume 116, Issue 6
J Clin Invest. 2006; 116(6):1713–1722 doi:10.1172/JCI25112
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 2
Phenotype of patients’ and NDs’ PBMCs.

(A) Dot plots of cell-surface expression of CD25. The percentage of CD4+CD25+ and CD4+CD25 T cells and relative MFI are indicated by the numbers in the plots. Intracytoplasmic CTLA4 and surface GITR expression are shown in histograms; gates for analysis were set on CD4+CD25 T cells (thin lines) and CD4+CD25+ T cells (thick lines), as shown in the dot plots. MFI values indicated in the histogram plots refer to the CD4+CD25+-gated cells. (B) Expression of CD45RA, CD62L, HLA-DR, and CD69 relative to CD25 in gated CD4+ T cells. Quadrants and regions of positive staining were set based on the isotype control (data not shown), and the numbers indicate the percentages of positive cells in each quadrant.